← Back to Search

HIIT for Heart Failure (CRpEF Trial)

N/A
Waitlist Available
Led By Steven Keteyian, PhD
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 10-12 weeks
Awards & highlights

CRpEF Trial Summary

This trial is testing the feasibility of higher intensity interval training (HIIT) for patients with heart failure with preserved ejection fraction (HFpEF). HIIT is a strategy that has been shown to be effective in other patients with cardiovascular disease (CVD).

Eligible Conditions
  • Heart Failure

CRpEF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 10-12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 10-12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in peak oxygen consumption from baseline

CRpEF Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Higher Intensity Interval Training (HIIT)Experimental Treatment1 Intervention
Group II: Moderate Continuous Training (MCT)Active Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HIIT
2011
N/A
~730

Find a Location

Who is running the clinical trial?

Henry Ford Health SystemLead Sponsor
300 Previous Clinical Trials
2,099,983 Total Patients Enrolled
9 Trials studying Heart Failure
1,389 Patients Enrolled for Heart Failure
Steven Keteyian, PhDPrincipal InvestigatorHenry Ford Health System
1 Previous Clinical Trials
282 Total Patients Enrolled
1 Trials studying Heart Failure
282 Patients Enrolled for Heart Failure

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025